Yunying Chen, NP

Yunying Chen practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Yunying Chen's NPI, 1558944520, was assigned on April 28, 2021. Yunying Chen holds California license 95015613.

Yunying Chen's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Yunying Chen's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Yunying Chen is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Yunying Chen to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Yunying Chen practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Yunying Chen's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Yunying Chen is licensed in California.

CMS counts 48 Medicare patients who saw Yunying Chen in 2024. The largest group is 65 to 74, with 18 patients. 73% of them have high blood pressure, and 73% have high cholesterol. 48% are also on Medicaid. Their average risk score is 3.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Yunying Chen's median patient age at 63, with 44% women.

In 2024, Yunying Chen wrote 317 Medicare Part D claims for 71 patients. 73% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Yunying Chen for performance year 2024, reported as part of a group. Yunying Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Yunying Chen as offering telehealth.

CMS Open Payments shows 31 general payments to Yunying Chen from 7 drug and device companies in 2025. Speaker and faculty fees make up the largest share, 40% of the total. Pfizer Inc. paid the most, $11,498.